ARS Investment Partners’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $37.2M | Sell |
|
|||||
|
2025
Q3 | $34.9M | Sell |
|
|||||
|
2025
Q2 | $36.2M | Sell |
|
|||||
|
2025
Q1 | $36.5M | Sell |
|
|||||
|
2024
Q4 | $36.5M | Buy |
|
|||||
|
2024
Q3 | $39.3M | Buy |
|
|||||
|
2024
Q2 | $34.5M | Sell |
|
|||||
|
2024
Q1 | $38.5M | Sell |
|
|||||
|
2023
Q4 | $35.6M | Sell |
|
|||||
|
2023
Q3 | $26.8M | Sell |
|
|||||
|
2023
Q2 | $25.9M | Buy |
|
|||||
|
2023
Q1 | $25.6M | Buy |
|
|||||
|
2022
Q4 | $29.1M | Buy |
|
|||||
|
2022
Q3 | $23.5M | Buy |
|
|||||
|
2022
Q2 | $14.6M | Buy |
|
|||||
|
2022
Q1 | $16.2M | Sell |
|
|||||
|
2021
Q4 | $18.8M | Buy |
|
|||||
|
2021
Q3 | $19.3M | Buy |
|
|||||
|
2021
Q2 | $10M | Buy |
|
|||||
|
2021
Q1 | $9.68M | Buy |
|
|||||
|
2020
Q4 | $9.86M | Buy |
|
|||||
|
2020
Q3 | $6.74M | Buy |
|
|||||
|
2020
Q2 | $4.52M | Sell |
|
|||||
|
2020
Q1 | $3.46M | Buy |
|
|||||
|
2019
Q4 | $2.1M | Buy |
|